Suzuki has finally launched the e-Access electric scooter in India at a surprising price of Rs 1,88,490 (ex-showroom, Delhi). Bookings are now open across all authorised Suzuki dealerships in the ...

The average price of gas around the U.S. this year is expected to dip to $2.97 per gallon, down 13 cents from 2025 — that would be the lowest level since 2020, according to a new analysis by GasBuddy.

Both companies are also expanding beyond obesity into adjacent conditions, which could reinforce the long-term investment case. Wegovy remains the only GLP-1 drug proven to reduce heart attacks and ...

The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. The Centers for Medicare & Medicaid Services (CMS) on Tuesday announced the Better ...

A new community legal clinic is launching in the spring. It’s a partnership between the province, Community Legal Information and the Law Foundation of P.E.I. CBC News: Compass host Louise Martin sat ...

PORTLAND, Ore. — After five years of absence, Portland's beloved Thompson Elk statue is on track to return to its historic home on Southwest Main Street by early spring 2026, city officials confirmed ...

Layoffs announced by employers declined on a monthly basis in November but still pushed the 2025 total to the highest level since the wave of pandemic-induced layoffs in 2020, new data from Challenger ...

Challenger, Gray & Christmas said layoff plans totaled 71,321 in November, a step down from the massive cuts announced in October but still enough to bring the 2025 total up to 1.17 million. The ...

Please provide your email address to receive an email when new articles are posted on . A pediatric obesity clinic partnered with a specialty pharmacy to reduce the burden of filling GLP-1 ...

The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which ...